Global and Regional Prostate Cancer Diagnostics Market Research Report 2017 [Report Updated: 18092017] Prices from USD $3500
Summary
The prostate is a walnutsized gland located behind the base of a man's penis, in front of the rectum, and below the bladder. Cancer begins when healthy cells in the prostate change and grow out of control, forming a tumor. A tumor can be cancerous or benign. A cancerous tumor is malignant, meaning it can grow and spread to other parts of the body. A benign tumor means the tumor can grow but will not spread.Prostate Cancer Diagnostics refers to using PSA, rectal exam, biopsy and others to diagnostic whether patients with breast cancer.
Market Segment as follows:
By Region
AsiaPacific
North America
Europe
South America
Middle East Africa
By Type
Tumor Biomarker Tests
Imaging
Biopsy
Others
By Application
< 55
5575
> 75
By Company
Abbott
Genomic Health
OPKO
Siemens Healthcare
DiaSorin
bioMeriux
Roche
MDx Health
Beckman Coulter
Myriad Genetics
Ambry Genetics
The main contents of the report including:
Section 1:
Product definition, type and application, global and regional market overview;
Section 2:
Global and regional Market competition by company;
Section 3:
Global and regional sales revenue, volume and price by type;
Section 4:
Global and regional sales revenue, volume and price by application;
Section 5:
Regional export and import;
Section 6:
Company information, business overview, sales data and product specifications;
Section 7:
Industry chain and raw materials;
Section 8:
SWOT and Porter's Five Forces;
Section 9:
Conclusion.
Original Article: Global and Regional Prostate Cancer Diagnostics Market Research Report 2017 [Report Updated: 18092017] Prices from USD $3500
